**Core Concept**
Anti-mitochondrial antibodies (AMA) are a type of autoantibody directed against the mitochondria, specifically the E2 subunit of the enzyme branched-chain alpha-keto acid dehydrogenase complex (BCKDC). AMA is a significant diagnostic marker for primary biliary cirrhosis (PBC), a chronic autoimmune liver disease.

**Why the Correct Answer is Right**
AMA is produced by activated T lymphocytes in response to the breakdown of the mitochondrial outer membrane. The E2 subunit of BCKDC is the primary antigenic target. These autoantibodies are highly specific for PBC and can be detected in 95-99% of patients with this condition. The presence of AMA is a key diagnostic criterion and has significant implications for the management and prognosis of PBC.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as AMA is not typically seen in autoimmune hepatitis, which is characterized by different autoantibodies such as anti-nuclear antibodies (ANA) and anti-smooth muscle antibodies (SMA).
**Option B:** This option is incorrect as AMA is not a marker for primary sclerosing cholangitis (PSC), a different autoimmune liver disease characterized by inflammation of the bile ducts.
**Option C:** This option is incorrect as AMA is not typically seen in Wilson's disease, a genetic disorder caused by mutations in the ATP7B gene leading to copper accumulation in the liver.

**Clinical Pearl / High-Yield Fact**
AMA is a highly specific marker for PBC, but its sensitivity is lower. A combination of clinical evaluation, laboratory tests, and imaging studies is necessary to establish a diagnosis.

**Correct Answer: A. Primary Biliary Cirrhosis (PBC)**